Sorcin, an important gene associated with multidrug-resistance in human leukemia cells
- 1 April 2006
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 30 (4), 469-476
- https://doi.org/10.1016/j.leukres.2005.08.024
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Expression of sorcin predicts poor outcome in acute myeloid leukemiaLeukemia Research, 2002
- Mammalian ABC Transporters in Health and DiseaseAnnual Review of Biochemistry, 2002
- Overexpression of sorcin, a calcium-binding protein, induces a low level of paclitaxel resistance in human ovarian and breast cancer cellsBiochemical Pharmacology, 2002
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Drug resistance factors in acute myeloid leukemia: a comparative analysisLeukemia, 2000
- Suppressive subtractive hybridisation reveals differential expression of serglycin, sorcin, bone marrow proteoglycan and prostate-tumour-inducing gene I (PTI-1) in drug-resistant and sensitive tumour cell lines of haematopoetic originEuropean Journal Of Cancer, 1999
- Correlation of P-glycoprotein expression and function in childhood acute leukemia: a children's cancer group studyBlood, 1996
- Isolation and molecular cloning of human sorcin a calcium-binding protein in vincristine-resistant H0B1 lymphoma cellsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1995
- Identification of a novel calcium-binding protein (CP22 ) in multidrug-resistant murine and hamster cellsFEBS Letters, 1986
- Increased synthesis of a low molecular weight protein in vincristine-resistant cellsBiochemical and Biophysical Research Communications, 1981